These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 149422

  • 21. [Complex compounds of heparin with blood proteins and their natural inhibitors in splenectomy in animals].
    Liapina LA, Kondashevskaia MV, Azieva LD, Soboleva GI.
    Patol Fiziol Eksp Ter; 1990; (4):20-2. PubMed ID: 2080078
    [Abstract] [Full Text] [Related]

  • 22. [The origin and physiological importance of activated plasminogen and plasmin in excitation of the anticoagulative system].
    Kudriashov BA, Liapina LA.
    Vopr Med Khim; 1973; 19(2):136-40. PubMed ID: 4267634
    [No Abstract] [Full Text] [Related]

  • 23. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].
    Shimonaeva EE, Liutova LV, Andreenko GV.
    Vopr Med Khim; 1981; 27(6):823-8. PubMed ID: 7199779
    [Abstract] [Full Text] [Related]

  • 24. [Role of intermediate products of prothrombin proteolysis by thrombin in the stimulation of the anticoagulation system of blood].
    Kudriashov BA, Strukova SM, Orlova AS, Liapina LA.
    Biull Eksp Biol Med; 1976 Oct; 82(10):1172-4. PubMed ID: 1029494
    [Abstract] [Full Text] [Related]

  • 25. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB, Bradford TR, Littman BH, Wintroub BU.
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [Abstract] [Full Text] [Related]

  • 26. [Complex compounds of plasminogen with heparin (PGH) and plasmin with heparin (PH) and their importance in regulating the liquid state of the blood].
    Kudriashov BA, Liapina LA.
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):28-30. PubMed ID: 4282511
    [No Abstract] [Full Text] [Related]

  • 27. [Formation of a secondary adrenaline-heparin-fibrinogen complex and its properties].
    Kudriashov BA, Liapina LA, Zhitnikova ES, Obraztsov VV.
    Vopr Med Khim; 1975 Apr; 21(1):65-9. PubMed ID: 1119113
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
    Moriau M, Rodhain J, Noel H, Beys-Col CD, Masure R.
    Thromb Diath Haemorrh; 1974 Sep 30; 32(1):171-88. PubMed ID: 4281540
    [Abstract] [Full Text] [Related]

  • 30. Glomerular fibrinolytic activity after thrombin perfusion in the rat.
    Sraer JD, Delarue F, Dard S, De Seigneux R, Morel-Maroger L, Kanfer A.
    Lab Invest; 1975 Apr 30; 32(4):515-7. PubMed ID: 123973
    [Abstract] [Full Text] [Related]

  • 31. [Thrombotic complications in the blocking effect of protamine sulfate on nonenzymatic fibrinolysis in the blood of animals during activation of the anticoagulation system].
    Liapina LA, Kudriashov BA.
    Vopr Med Khim; 1979 Apr 30; 25(2):209-14. PubMed ID: 442592
    [Abstract] [Full Text] [Related]

  • 32. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH, Diamond SL.
    Thromb Haemost; 1995 Aug 30; 74(2):711-7. PubMed ID: 8585011
    [Abstract] [Full Text] [Related]

  • 33. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
    Martin H, Auel H, Riedel C.
    Behring Inst Mitt; 1986 Feb 30; (79):263-71. PubMed ID: 2424424
    [Abstract] [Full Text] [Related]

  • 34. [Activation of the anticoagulant system by prethrombin 2, a thrombin precursor].
    Strukova SM, Umarova BA, Gribkova NN, Kudriashov BA.
    Biull Eksp Biol Med; 1980 Mar 30; 89(3):270-2. PubMed ID: 6966943
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Activation of the fibrinolytic system following subcutaneous administration and inhalation of heparin].
    Psuja P, Tokarz A, Turowiecka Z, Sowier J, Zawilska K.
    Pol Tyg Lek; 1980 Mar 30; 48(5-6):105-8. PubMed ID: 8361902
    [Abstract] [Full Text] [Related]

  • 37. [Significance of a relative excess of vitamin A and unsaturated fatty acids in the formation of complex heparin compounds under stress in animals maintained on natural and atherogenic rations].
    Kudriashov BA, Bazaz'ian GG, Liapina LA, Sytina NP.
    Vopr Pitan; 1973 Mar 30; 32(1):23-9. PubMed ID: 4273549
    [No Abstract] [Full Text] [Related]

  • 38. [Effect of complexes of heparin with plasma proteins on the anticoagulant and fibrinolytic activity of blood].
    Kudriashov BA, Pastorova VE, Liapina LA.
    Fiziol Zh SSSR Im I M Sechenova; 1986 Dec 30; 72(12):1653-8. PubMed ID: 3817209
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Amidolytic activity of plasma euglobulins.
    Jasielczuk J, Dabrowka M, Gacko M, Jankiewicz M.
    Rocz Akad Med Bialymst; 2004 Dec 30; 49 Suppl 1():250-1. PubMed ID: 15638440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.